Expression of suppressor of cytokine signaling 1 (SOCS1) gene dramatically increases in relapsing–remitting multiple sclerosis
- 1 March 2015
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 350 (1-2) , 40-45
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Incidence and prevalence of multiple sclerosis in southeastern IranClinical Neurology and Neurosurgery, 2013
- SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-γ and IL-17A productionJournal of Experimental Medicine, 2011
- Increased Expression of Suppressor of Cytokine Signaling 1 mRNA in Patients With Rheumatoid ArthritisThe Kaohsiung Journal of Medical Sciences, 2010
- Trait-Associated SNPs Are More Likely to Be eQTLs: Annotation to Enhance Discovery from GWASPLOS Genetics, 2010
- Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibilityHuman Genetics, 2010
- Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and functionTrends in Immunology, 2009
- Mapping complex disease traits with global gene expressionNature Reviews Genetics, 2009
- Estrogen and testosterone therapies in multiple sclerosis2009
- The single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction: twenty-something years onNature Protocols, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001